Gregory George Purchases 74,621 Shares of Mesoblast Limited (ASX:MSB) Stock

Mesoblast Limited (ASX:MSB) insider Gregory George bought 74,621 shares of the stock in a transaction on Monday, March 10th. The stock was purchased at an average price of A$12.88 ($8.20) per share, for a total transaction of A$961,118.48 ($612,177.38).

Gregory George also recently made the following trade(s):

• On Monday, March 3rd, Gregory George acquired 5,034,129 shares of Mesoblast stock. The shares were bought at an average price of A$2.95 ($1.88) per share, for a total transaction of A$14,830,544.03 ($9,446,206.39).

Mesoblast Stock Performance

The company has a debt-to-equity ratio of 24.76, a quick ratio of 1.82 and a current ratio of 1.18. The stock has a market cap of $2.32 billion, a price-to-earnings ratio of -23.29, a price-to-earnings-growth ratio of 9.56 and a beta of 2.38.

Mesoblast Company Profile

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.